Latest Post

March 02, 2021

Understanding Risks of Coring and Fragmentation of Rubber Stoppers

When it comes to choosing the right container closure system, a significant amount of focus is directed at addressing issues that may be a risk to safety and efficacy of the parenteral drug before it is introduced to a patient. Examples are testing of container closure integrity (CCI) and drug stability. Prior to drug administration by a health care professional, the rubber stopper is pierced with a needle, at least once. Stopper puncture testing also needs to be considered, especially if the closure system will be used in a multi-dose application.
Bjoern Henze

Björn Henze

Manager, TCS. Commercial, EU

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Bettine Boltres presents at PDA Webinar

    August 24, 2020

    How to Include Elastomers in the Nitrosamine Risk Assessment

    Bettine Boltres

    Dr. Bettine Boltres

    Principal Scientific Affairs, Packaging & Delivery Systems

    AccelTRA Components Program

    June 26, 2020

    Performance of AccelTRA® Components

    Qian Liu

    Nancy Liu

    Senior Specialist, TCS, China

    By Your Side for Collaboration

    July 24, 2019

    Scientific Insight Enables Risk Mitigation: Why West is By our Customers’ Side

    Fran DeGrazio

    Fran DeGrazio

    Vice President, Technical Services & Scientific Affairs

    West logo with Diamond

    March 12, 2012

    Managing Total Cost of Ownership in a Changing Market

    West Pharma

    Fran DeGrazio

    VP, Scientific Affairs & Technical Services